3M Closes €1.5B Note Offering due 2028-2034

3M’s completed €1.5 billion note offering increases available capital across multiple maturities (2028–2034) and is identified by the company as intended for general corporate purposes. The offering is euro-denominated and complements the $4.25 billion unsecured revolving credit facility the company established on 2026-08-19. Together, those facilities broaden 3M’s financing mix and extend funding across short- and medium-term horizons. From an investor perspective, the size of the euro issuance should be considered alongside 3M’s revenue scale: total company net sales were $6,344 million in Q2 2025 and $12,298 million for the first half of 2025. The company’s three reportable segments — Safety & Industrial (45.7% of Q2 2025 reportable sales), Transportation & Electronics (34.0%), and Consumer (20.3%) — remain the primary cash generators supporting corporate obligations.

Issuing euro-denominated notes gives 3M access to European investor demand and matches currency exposures for corporate needs in Europe. The offering’s maturity ladder (2028–2034) staggers repayments across a multi-year window, which can help manage refinancing needs and cash-flow timing for the company. The company has cited structural actions over 2023–2025 to simplify operations, reduce corporate center size and streamline the geographic footprint. Those ongoing execution initiatives are part of management’s near-term focus on improving operating efficiency and aligning capital use with adjusted EPS growth, organic sales and free cash flow objectives.

3M continues to face material legal and remediation exposures that are relevant to financing strategy and corporate use of proceeds. Notable items disclosed in company filings include: - PFAS-related litigation and remediation: a public water supplier settlement totaling $12.5 billion (3M’s portion roughly $10.3 billion) became effective May 2024, with extensive ongoing litigation globally and remediation commitments including estimated remediation spending (e.g., Zwijndrecht remediation commitment of €571 million). The company announced plans to cease manufacturing/use of certain PFAS by end-2025. - Combat Arms Earplugs (CAE): a multi-year settlement framework through 2029 with a $6.0 billion aggregate settlement; 3M had $2.4 billion accrued as of Q2 2025 and reported participation thresholds met with $1.4 billion paid out to date. - Other legacy and environmental matters: respirator/asbestos (Aearo) claims, notice of violations for wastewater and stormwater at certain facilities, and other site investigations. These liabilities and remediation obligations are part of the broader funding backdrop against which the euro note offering was executed. The company’s filings also note ongoing restructuring charges (2023–2025) and a transfer of pension obligations in Apr 2024, which are material items for capital planning.